Fidelity Disruptive Medicine ETF Rating $25.74 +0.21 (+0.82%) (As of 11/1/2024 ET) Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestTrends Fidelity Disruptive Medicine ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.FMED Aggregate RatingModerate Buy2.77Holdings in FMED have an aggregate rating of Moderate Buy based on 703 analyst ratings issued in the past year covering 46 companies (90.5% of the portfolio).FMED Aggregate Price Target$31.1621.05% UpsideHigh Prediction$38.04Average Prediction$31.16Low Prediction$23.19Holdings in FMED have an aggregate price target of $31.16 and a range of $23.19 to $38.04 covering 46 companies (90.5% of the portfolio).FMED Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy7 Buy rating(s)Moderate Buy33 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Fidelity Disruptive Medicine ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 46 FMED Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings6.11%BSXBoston Scientific$83.62-0.5%4.8538 of 5 stars2.91$93.39 11.7%23Analyst Forecast5.00%ALNYAlnylam Pharmaceuticals$273.91+2.7%3.9488 of 5 stars2.75$294.50 7.5%24Analyst ForecastShort Interest ↑News Coverage4.62%UNHUnitedHealth Group$567.56+0.5%4.9013 of 5 stars2.95$615.53 8.5%22Positive News3.97%ISRGIntuitive Surgical$506.34+0.5%4.8429 of 5 stars2.68$513.74 1.5%19Insider SellingShort Interest ↓3.83%PODDInsulet$235.61+1.8%4.5248 of 5 stars2.79$242.29 2.8%14Upcoming EarningsNews Coverage3.78%EXASExact Sciences$69.80+1.3%4.2486 of 5 stars2.94$80.64 15.5%16Upcoming EarningsAnalyst ForecastShort Interest ↑3.65%DHRDanaher$247.82+0.9%4.9218 of 5 stars2.74$287.16 15.9%19Analyst UpgradeShort Interest ↓3.37%REGNRegeneron Pharmaceuticals$843.60+0.6%4.8471 of 5 stars2.73$1,090.24 29.2%22Analyst ForecastAnalyst RevisionNews CoverageHigh Trading Volume2.91%ARGXargenx$595.58+1.6%2.5957 of 5 stars2.86$582.50 -2.2%23Earnings ReportAnalyst ForecastShort Interest ↓Analyst RevisionNews Coverage2.54%LLYEli Lilly and Company$818.93-1.3%4.9073 of 5 stars2.84$1,009.00 23.2%19Earnings ReportDividend AnnouncementAnalyst ForecastAnalyst Revision2.49%SYKStryker$367.15+3.1%4.9313 of 5 stars2.80$393.65 7.2%20Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage2.46%LEGNLegend Biotech$44.36-1.5%2.0739 of 5 stars3.00$82.08 85.0%14Analyst Forecast2.31%LFSTLifeStance Health Group$6.81+1.5%1.192 of 5 stars2.17$8.25 21.1%6Upcoming Earnings2.26%PENPenumbra$233.38+2.0%3.9071 of 5 stars2.71$226.67 -2.9%14Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage2.21%INSPInspire Medical Systems$190.67-2.2%4.7114 of 5 stars2.67$219.58 15.2%12Upcoming EarningsNews Coverage2.05%TMOThermo Fisher Scientific$557.92+2.1%4.9673 of 5 stars2.86$649.33 16.4%22Insider Selling1.97%VEEVVeeva Systems$212.80+1.9%4.5053 of 5 stars2.61$232.87 9.4%23Analyst Downgrade1.91%PCVXVaxcyte$107.29+0.9%3.1349 of 5 stars3.00$147.50 37.5%7Upcoming EarningsPositive News1.90%MRKMerck & Co., Inc.$101.87-0.4%5 of 5 stars2.88$129.93 27.5%17Earnings ReportAnalyst ForecastNews Coverage1.90%RPRXRoyalty Pharma$27.10+0.4%4.7664 of 5 stars2.83$41.67 53.8%6Upcoming Earnings1.74%MASIMasimo$144.22+0.1%3.3297 of 5 stars2.57$145.33 0.8%7Upcoming Earnings1.66%TECHBio-Techne$75.31+2.1%4.1793 of 5 stars2.67$81.78 8.6%9Dividend AnnouncementAnalyst ForecastNews Coverage1.59%EWEdwards Lifesciences$67.54+0.8%4.6338 of 5 stars2.38$75.67 12.0%26Analyst DowngradeShort Interest ↓Analyst RevisionNews Coverage1.49%RMDResMed$244.28+0.7%4.5108 of 5 stars2.50$225.70 -7.6%12Gap Up1.41%RGENRepligen$138.61+3.2%4.8053 of 5 stars2.80$190.25 37.3%10News CoveragePositive News1.30%ZLABZai Lab$30.46+0.8%3.097 of 5 stars3.00$52.50 72.4%41.29%BRKRBruker$59.29+4.7%4.9082 of 5 stars2.55$80.82 36.3%11Upcoming Earnings1.27%KROSKeros Therapeutics$59.94+3.3%3.4249 of 5 stars3.00$89.11 48.7%11Upcoming EarningsShort Interest ↓Positive News1.26%GKOSGlaukos$131.70-0.4%3.6946 of 5 stars2.73$130.45 -0.9%11Upcoming EarningsInsider Selling1.25%JANXJanux Therapeutics$54.39+0.7%2.9828 of 5 stars2.90$66.44 22.2%10Upcoming EarningsInsider SellingNews Coverage1.22%CNCCentene$63.52+2.0%4.9559 of 5 stars2.50$84.00 32.2%14Analyst Forecast1.16%CYTKCytokinetics$51.82+1.6%4.2687 of 5 stars2.73$83.93 62.0%15Upcoming EarningsInsider SellingShort Interest ↓1.15%XENEXenon Pharmaceuticals$41.69+1.4%3.4499 of 5 stars3.08$57.45 37.8%12Options VolumeNews CoveragePositive News1.11%SRPTSarepta Therapeutics$123.29-2.2%4.9531 of 5 stars2.95$182.95 48.4%21Upcoming Earnings1.07%PRVAPrivia Health Group$18.99+3.4%3.6506 of 5 stars3.00$24.73 30.2%16Upcoming EarningsNews Coverage1.01%DXCMDexCom$70.35-0.2%4.9945 of 5 stars2.72$104.59 48.7%18Analyst Downgrade0.99%VRTXVertex Pharmaceuticals$471.12-1.0%3.4636 of 5 stars2.48$492.50 4.5%29Upcoming EarningsAnalyst Forecast0.93%PHRPhreesia$18.47+1.0%4.4322 of 5 stars2.92$29.42 59.3%120.93%DOCSDoximity$42.35+1.5%3.5475 of 5 stars2.33$36.42 -14.0%15Upcoming EarningsAnalyst ForecastNews Coverage0.92%HUMHumana$260.71+1.1%4.9021 of 5 stars2.20$315.48 21.0%25Earnings ReportAnalyst Forecast0.90%ASNDAscendis Pharma A/S$125.28+2.0%3.0734 of 5 stars2.92$195.92 56.4%13Upcoming Earnings0.86%WSTWest Pharmaceutical Services$316.50+2.8%4.8952 of 5 stars2.67$460.33 45.4%3Insider Selling0.75%TNDMTandem Diabetes Care$31.91+1.7%4.5355 of 5 stars2.76$55.13 72.8%17Upcoming EarningsPositive News0.74%ALGNAlign Technology$208.58+1.7%4.9544 of 5 stars2.40$276.38 32.5%10Gap Up0.68%TXG10x Genomics$16.33+1.9%4.5753 of 5 stars2.53$29.19 78.7%17Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage0.62%ACLXArcellx$86.17+2.3%1.5072 of 5 stars3.08$89.75 4.2%13Analyst ForecastShort Interest ↑News Coverage This page (NASDAQ:FMED) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | Sponsored[Just Released] Jovine's Emergency Briefing insidePeople didn't believe Jovine when he predicted the 2008 financial crisis over a year in advance. But some read...Behind the Markets | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fidelity Disruptive Medicine ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Fidelity Disruptive Medicine ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
